Organon (OGN) Enterprise Value (2020 - 2026)
Organon (OGN) posted quarterly Enterprise Value of -$1.1 billion for Q2 2026, down 88.98% year-over-year from -$10.3 billion in Q2 2025, and down 1.43% on a QoQ basis from -$1.1 billion in Q1 2026.
Organon (OGN) Enterprise Value (2020 - 2026) Analysis & Trends
Organon has reported Enterprise Value for 7 years, with the latest figure at -$1.1 billion in Q2 2026.
- Enterprise Value for Q2 2026 came in at -$1.1 billion, down 88.98% year-over-year; the trailing twelve-month figure through Jun 2026 was -$1.1 billion (down 88.98% YoY), and the FY2025 annual result was -$574.0 million, up 18.47% from the prior year.
- Enterprise Value eased to -$1.1 billion in Q2 2026, from -$1.1 billion in the prior quarter.
- Over five years, Enterprise Value peaked at -$326.0 million in Q2 2023 and troughed at -$1.1 billion in Q2 2026.
- A 5-year average of -$651.7 million and a median of -$635.5 million in 2025 frame the typical range for Enterprise Value.
- The largest YoY upside for Enterprise Value was 50.5% in 2022 against a maximum downside of 392.2% in 2022.
- A 5-year view of Enterprise Value shows it stood at -$706.0 million in 2022, then increased by 0.57% to -$702.0 million in 2023, then fell by 0.28% to -$704.0 million in 2024, then rose by 18.47% to -$574.0 million in 2025, then sank by 97.21% to -$1.1 billion in 2026.
- Per Business Quant data, the three most recent Enterprise Value figures were -$1.1 billion in Q2 2026, -$1.1 billion in Q1 2026, and -$574.0 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.88 Bn | 625.12 Bn | 17.26 Bn | -20.76 Bn |
| 2 | AbbVie | 463.46 Bn | 456.89 Bn | 12.70 Bn | -6.52 Bn |
| 3 | Merck | 367.92 Bn | 360.78 Bn | 12.21 Bn | -7.09 Bn |
| 4 | Novartis Ag | 297.71 Bn | 290.02 Bn | 11.24 Bn | -7.69 Bn |
| 5 | Astrazeneca | 255.55 Bn | 250.65 Bn | 12.86 Bn | -4.90 Bn |
| 6 | Amgen | 234.52 Bn | 220.53 Bn | 7.24 Bn | -13.99 Bn |
| 7 | Gilead Sciences | 178.22 Bn | 175.04 Bn | 6.22 Bn | -3.26 Bn |
| 8 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | -11.40 Bn |
| 9 | Gsk | 105.32 Bn | 101.15 Bn | 8.24 Bn | -4.80 Bn |
| 10 | Organon | 3.61 Bn | 2.47 Bn | 847.00 Mn | -1.13 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.13 Bn |
| Mar 31, 2026 | -1.12 Bn |
| Dec 31, 2025 | -574.00 Mn |
| Sep 30, 2025 | -672.00 Mn |
| Jun 30, 2025 | -599.00 Mn |
| Mar 31, 2025 | -547.00 Mn |
| Dec 31, 2024 | -704.00 Mn |
| Sep 30, 2024 | -763.00 Mn |
| Jun 30, 2024 | -704.00 Mn |
| Mar 31, 2024 | -575.00 Mn |
| Dec 31, 2023 | -702.00 Mn |
| Sep 30, 2023 | -414.00 Mn |
| Jun 30, 2023 | -326.00 Mn |
| Mar 31, 2023 | -459.00 Mn |
| Dec 31, 2022 | -706.00 Mn |
| Sep 30, 2022 | -499.00 Mn |
| Jun 30, 2022 | -545.00 Mn |
| Mar 31, 2022 | -694.00 Mn |
| Dec 31, 2021 | -737.00 Mn |
| Sep 30, 2021 | -1.01 Bn |